X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
male (21) 21
pharmacology & pharmacy (19) 19
adult (16) 16
index medicus (14) 14
middle aged (13) 13
female (12) 12
genotype (11) 11
pharmacokinetics (9) 9
polymorphism, genetic - genetics (9) 9
genetic aspects (8) 8
medicine, general & internal (7) 7
pharmacodynamics (7) 7
aged (6) 6
cytochrome p-450 cyp2c9 (6) 6
sulfonamides - pharmacokinetics (6) 6
adolescent (5) 5
aryl hydrocarbon hydroxylases - genetics (5) 5
diuretics (5) 5
genetic polymorphisms (5) 5
hypertension (5) 5
metabolism (5) 5
phenotype (5) 5
polymorphisms (5) 5
research (5) 5
safety (5) 5
young adult (5) 5
animals (4) 4
area under curve (4) 4
cross-over studies (4) 4
diuretics - pharmacokinetics (4) 4
diuretics - pharmacology (4) 4
haplotype reconstruction (4) 4
pharmacogenetics (4) 4
polymorphism, genetic (4) 4
population (4) 4
psychiatry (4) 4
therapy (4) 4
torsemide (4) 4
variants (4) 4
administration, oral (3) 3
aldosterone (3) 3
alleles (3) 3
analysis (3) 3
anticoagulants - administration & dosage (3) 3
aryl hydrocarbon hydroxylases - metabolism (3) 3
association (3) 3
blood (3) 3
clinical trials (3) 3
cytochrome p4502c9 polymorphisms (3) 3
drug therapy (3) 3
drugs (3) 3
expression (3) 3
genetics & heredity (3) 3
haplotypes (3) 3
hydrochlorothiazide (3) 3
internal medicine (3) 3
kidney - metabolism (3) 3
multiple sclerosis (3) 3
patients (3) 3
pharmacology (3) 3
polymorphism, single nucleotide (3) 3
potassium (3) 3
potassium - urine (3) 3
studies (3) 3
surgery (3) 3
surveys and questionnaires (3) 3
abridged index medicus (2) 2
alpha-adducin (2) 2
alzheimer's disease (2) 2
amyloid precursor protein (2) 2
analgesics, opioid - metabolism (2) 2
anticoagulants (2) 2
antihypertensive therapy (2) 2
atrial-fibrillation (2) 2
bioavailability (2) 2
biological availability (2) 2
biotransformation (2) 2
blood suction (2) 2
blood-pressure (2) 2
bumetanide - pharmacology (2) 2
cardiac & cardiovascular systems (2) 2
care and treatment (2) 2
cluster analysis (2) 2
codeine (2) 2
codeine - analogs & derivatives (2) 2
codeine - metabolism (2) 2
comparative analysis (2) 2
creatinine - metabolism (2) 2
cyp2d6 (2) 2
cyp3a4 (2) 2
cytochrome p-450 cyp2d6 - metabolism (2) 2
data processing (2) 2
dihydromorphine (2) 2
diuretics - therapeutic use (2) 2
dna - genetics (2) 2
dosage and administration (2) 2
dose-response relationship, drug (2) 2
double-blind (2) 2
double-blind method (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLOS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, p. e0173353
Background This study compared outcomes following fingolimod or BRACE treatments (beta-interferons/glatiramer acetate) in patients with active MS (>= 1 relapse... 
REMITTING MULTIPLE-SCLEROSIS | ORAL FINGOLIMOD | BETA THERAPY | INTRAMUSCULAR INTERFERON | MULTIDISCIPLINARY SCIENCES | DISEASE | DOUBLE-BLIND | NATALIZUMAB | COHORT | CLINICAL-RELEVANCE | FREEDOMS II | Humans | Middle Aged | Male | Interferons - therapeutic use | Disease Progression | Young Adult | Glatiramer Acetate - therapeutic use | Adolescent | Aged, 80 and over | Multiple Sclerosis - pathology | Adult | Female | Aged | Fingolimod Hydrochloride - therapeutic use | Germany | Cohort Studies | Multiple Sclerosis - drug therapy | Glatiramer acetate | Treatment outcome | Multiple sclerosis | Fingolimod | Analysis | Dosage and administration | Drug therapy | Comparative analysis | Elderly people | Brain | Therapy | Jaw | Physical training | Copolymer 1 | Central nervous system | Cognitive ability | Nervous system | Leukoencephalopathy | Recovery | Epidemiology | Data bases | Progressive multifocal leukoencephalopathy | Pharmaceutical industry | Economics | Documentation | Quality of life | Studies | Neurology | FTY720 | Health care | Neuroimaging | Nuclear magnetic resonance--NMR | β-Interferon | Medical services | Clinical trials | Chin | Marketing | Atrophy | Confidence intervals | Accessories | Databases | Risk assessment | Remission | Barometers | Safety | Lesions | Receiving | Effectiveness | Health | Pharmacology | Switching | Brain research | Magnetic resonance imaging | Pharmacoeconomics | Resonance | Interferon | Nuclear magnetic resonance | NMR
Journal Article
NATURE REVIEWS GENETICS, ISSN 1471-0056, 12/2007, Volume 8, Issue 12
Journal Article
Pharmacogenomics Journal, ISSN 1470-269X, 2012, Volume 12, Issue 1, pp. 45 - 53
Journal Article
CLINICAL PHARMACOLOGY & THERAPEUTICS, ISSN 0009-9236, 03/2009, Volume 85, Issue 3, pp. 273 - 276
The impact of the CYP2C9 polymorphism on the pharmacokinetics of orally administered Delta 9-tetrahydrocannabinol (THC) was studied in 43 healthy volunteers.... 
METABOLISM | TETRAHYDROCANNABINOL | DRUGS | DELTA-TETRAHYDROCANNABINOL | PHARMACOLOGY & PHARMACY | HEPATIC MICROSOMES | DRIVERS | CYTOCHROME P4502C9 POLYMORPHISMS | CANNABINOIDS | DISPOSITION | BLOOD
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2013, Volume 35, Issue 8, pp. e14 - e14
Journal Article